Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Thorax”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03366103
What this trial is testing

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmRecurrent Lung Small Cell CarcinomaRecurrent Malignant Solid Neoplasm+6 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00770120
What this trial is testing

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 61
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Not applicableStudy completedNCT03676426
What this trial is testing

Comparison of a Web-based Advance Directive to a Standard Advance Directive

Who this might be right for
GI CancerThoracic Cancer
University of Pennsylvania 90
Early research (Phase 1)Active Not RecruitingNCT03546426
What this trial is testing

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

Who this might be right for
Mesothelioma, MalignantPD-L1 NegativeAdvanced Cancer+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 18
Testing effectiveness (Phase 2)Study completedNCT05659576
What this trial is testing

Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation

Who this might be right for
Radiation Esophagitis
Memorial Sloan Kettering Cancer Center 142
Early research (Phase 1)Study completedNCT01014598
What this trial is testing

Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis

Who this might be right for
Metastatic Malignant Neoplasm in the LungStage IIIB Non-Small Cell Lung CancerStage IV Adult Soft Tissue Sarcoma+1 more
Roswell Park Cancer Institute 11
Not applicableUnknownNCT02761863
What this trial is testing

Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06769295
What this trial is testing

A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC

Who this might be right for
Lung Cancer, Non-Small Cell
Sichuan University 28
Not applicableStudy completedNCT03597828
What this trial is testing

Respiratory Function of Dexmedetomidine in Patients Undergoing Pleuroscopy

Who this might be right for
Pleural Effusions, ChronicPleural Effusion, MalignantPleural Diseases
Attikon Hospital 60
Early research (Phase 1)Ended earlyNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Not applicableEnded earlyNCT00748085
What this trial is testing

CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)

Who this might be right for
Lung CancerMesothelioma
CSA Medical, Inc. 5
Not applicableStudy completedNCT06657638
What this trial is testing

Cytological Examination of Malignant Pleural Effusion in Breast Cancer

Who this might be right for
Malignant Pleural Effusion
Mansoura University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02497508
What this trial is testing

Nivolumab in Patients With Recurrent Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 33
Testing effectiveness (Phase 2)Ended earlyNCT02459067
What this trial is testing

ImmuniCell® in Patients With Advanced Cancers

Who this might be right for
Malignant MelanomaNon-small Cell Lung CancerRenal Cell Cancer
TC Biopharm 8
Large-scale testing (Phase 3)Study completedNCT00347412
What this trial is testing

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Cellectar Biosciences, Inc. 903
Not applicableStudy completedNCT00897247
What this trial is testing

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

Who this might be right for
Malignant MesotheliomaPulmonary Complications
Barbara Ann Karmanos Cancer Institute 494
Not applicableWithdrawnNCT06494046
What this trial is testing

Defining Musical Toxicity and Its Effect on Patient Well-being

Who this might be right for
Breast CarcinomaEsophageal CarcinomaHead and Neck Carcinoma+3 more
Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Looking for participantsNCT06251310
What this trial is testing

SW-682 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMesothelioma, Malignant
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 186
Next Page